7.21
price down icon1.23%   -0.09
after-market Handel nachbörslich: 7.21
loading

Myriad Genetics Inc Aktie (MYGN) Neueste Nachrichten

pulisher
02:20 AM

What analysts say about Myriad Genetics Inc stockStock Screening Results & The Smart Money Is Buying These Picks - earlytimes.in

02:20 AM
pulisher
Dec 10, 2025

Discipline and Rules-Based Execution in MYGN Response - news.stocktradersdaily.com

Dec 10, 2025
pulisher
Dec 09, 2025

Why Myriad Genetics (MYGN) Stock Is Up Today - Finviz

Dec 09, 2025
pulisher
Dec 09, 2025

Myriad Genetics to Showcase Advances in Hereditary Cancer and MRD Testing at 2025 San Antonio Breast Cancer Symposium - Quiver Quantitative

Dec 09, 2025
pulisher
Dec 09, 2025

Myriad Genetics (NASDAQ: MYGN) spotlights MRD and MyRisk data in 8 SABCS 2025 abstracts - Stock Titan

Dec 09, 2025
pulisher
Dec 08, 2025

Myriad Genetics (MYGN): Buy, Sell, or Hold Post Q3 Earnings? - TradingView

Dec 08, 2025
pulisher
Dec 06, 2025

Prudential Financial Inc. Has $1.82 Million Stock Position in Myriad Genetics, Inc. $MYGN - MarketBeat

Dec 06, 2025
pulisher
Dec 05, 2025

Fisher Asset Management LLC Purchases 219,607 Shares of Myriad Genetics, Inc. $MYGN - MarketBeat

Dec 05, 2025
pulisher
Dec 04, 2025

What MACD trends signal for Myriad Genetics Inc. (MYD) stock2025 Market Sentiment & Free Reliable Trade Execution Plans - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Why Myriad Genetics Inc. stock appeals to analystsWeekly Trend Summary & Free Expert Approved Momentum Trade Ideas - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Can Myriad Genetics Inc. stock continue upward trendMarket Trend Review & Low Drawdown Trading Techniques - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Why Is Myriad (MYGN) Up 8.7% Since Last Earnings Report? - MSN

Dec 03, 2025
pulisher
Dec 03, 2025

Upcoming Virtual Meeting on December 11 Hosted by Craig-Hallum f - GuruFocus

Dec 03, 2025
pulisher
Dec 03, 2025

4D Path’s Physics-Inspired QPOR™ Platform Predicts Neoadjuvant Chemotherapy Response from Routine Biopsy Images in Early-Stage Triple-Negative Breast Cancer from Phase II TBCRC-030 Trial - GlobeNewswire Inc.

Dec 03, 2025
pulisher
Dec 02, 2025

1 Healthcare Stock with Promising Prospects and 2 We Question - Barchart.com

Dec 02, 2025
pulisher
Dec 02, 2025

How Myriad Genetics Inc. stock benefits from strong dollarTrade Risk Assessment & Low Drawdown Investment Ideas - Newser

Dec 02, 2025
pulisher
Dec 01, 2025

Why Myriad Genetics (MYGN) Stock Is Trading Lower Today - Finviz

Dec 01, 2025
pulisher
Nov 30, 2025

Myriad Genetics, Inc. $MYGN Stock Holdings Lifted by XTX Topco Ltd - MarketBeat

Nov 30, 2025
pulisher
Nov 28, 2025

Myriad Genetics Outpaces Expectations But Faces Profit Challenges - Finimize

Nov 28, 2025
pulisher
Nov 28, 2025

How Recent Developments Are Shaping the Myriad Genetics Investment Story - Yahoo Finance

Nov 28, 2025
pulisher
Nov 27, 2025

UBS Initiates Coverage of Myriad Genetics (MYGN) with Neutral Recommendation - MSN

Nov 27, 2025
pulisher
Nov 27, 2025

Will Myriad Genetics Inc. stock return to pre crisis levelsJuly 2025 Outlook & Breakout Confirmation Trade Signals - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 27, 2025

Jaffetilchin Investment Partners LLC Buys New Shares in Myriad Genetics, Inc. $MYGN - MarketBeat

Nov 27, 2025
pulisher
Nov 27, 2025

Will Myriad Genetics Inc. stock attract more institutional investorsPortfolio Growth Summary & Real-Time Buy Signal Notifications - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 26, 2025

Myriad Genetics, Inc. (MYGN) Stock Forecasts - Yahoo Finance

Nov 26, 2025
pulisher
Nov 26, 2025

How Myriad Genetics achieved fast, accurate, and cost-efficient document processing using the AWS open-source Generative AI Intelligent Document Processing Accelerator - Amazon Web Services (AWS)

Nov 26, 2025
pulisher
Nov 26, 2025

Earnings Recap: Can Myriad Genetics Inc. stock double in next 5 yearsTake Profit & Free Safe Entry Trade Signal Reports - BỘ NỘI VỤ

Nov 26, 2025
pulisher
Nov 26, 2025

Myriad Genetics, Neogen, ICU Medical, HCA Healthcare, and Universal Health Services Stocks Trade Up, What You Need To Know - MSN

Nov 26, 2025
pulisher
Nov 26, 2025

Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health - The Manila Times

Nov 26, 2025
pulisher
Nov 25, 2025

Clairity, Myriad Genetics, MagView partner on breast cancer risk tools By Investing.com - Investing.com Nigeria

Nov 25, 2025
pulisher
Nov 25, 2025

Myriad Genetics partners to use AI to measure breast cancer risk - Seeking Alpha

Nov 25, 2025
pulisher
Nov 25, 2025

Clairity, Myriad Genetics, MagView partner on breast cancer risk tools - Investing.com

Nov 25, 2025
pulisher
Nov 25, 2025

Clairity, Myriad Genetics, and MagView Collaborate to Enhance Breast Cancer Risk Assessment Tool - Quiver Quantitative

Nov 25, 2025
pulisher
Nov 25, 2025

Clairity, Myriad Genetics, Inc. and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health - marketscreener.com

Nov 25, 2025
pulisher
Nov 25, 2025

Myriad Genetics (NASDAQ: MYGN), Clairity and MagView launch AI breast risk platform - Stock Titan

Nov 25, 2025
pulisher
Nov 24, 2025

Myriad Genetics joins Forbes list of America's dream employers for 2026 - Traders Union

Nov 24, 2025
pulisher
Nov 24, 2025

Myriad Genetics Inc Stock Analysis and ForecastSmall Cap Stock Opportunities & Low Entry Cost Capital - earlytimes.in

Nov 24, 2025
pulisher
Nov 22, 2025

Myriad Genetics Q3 2025 Earnings Preview - MSN

Nov 22, 2025
pulisher
Nov 21, 2025

Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know - Yahoo Finance

Nov 21, 2025
pulisher
Nov 21, 2025

Can Myriad Genetics Inc. stock sustain market leadershipMarket Activity Report & Real-Time Volume Spike Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is Myriad Genetics Inc. (MYD) stock nearing a technical breakout2025 Key Highlights & Detailed Earnings Play Strategies - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will Myriad Genetics Inc. stock benefit from sector rotationJuly 2025 Technicals & Entry Point Strategy Guides - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Why analysts upgrade Myriad Genetics Inc. stockJuly 2025 Big Picture & Technical Pattern Recognition Alerts - newser.com

Nov 21, 2025
$134.87
price down icon 1.15%
diagnostics_research LH
$264.18
price down icon 0.21%
diagnostics_research WAT
$385.33
price down icon 1.75%
diagnostics_research MTD
$1,393.64
price down icon 1.97%
$231.95
price up icon 0.39%
diagnostics_research IQV
$222.26
price down icon 1.65%
Kapitalisierung:     |  Volumen (24h):